7.200
+2,86%
2026-10-08
Fundamental Analysis
35 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -47.5% | +89.3% | 1 / 3 | +5.2% | -0.73 pp | -1.07 pp | -21.2% | 1.25 | — | 309 | +5,2% | 2,1 | −59,1% | — | 6.00 | — |
| Pts | 0 | 12 | 4 | 0 | 4 | 4 | 0 | 6 | 8 | |||||||
Valuation annotation:Price: 7.200 (close price on 2026-10-08)EPS (TTM): −4.029,6
Financial charts
1.Revenue & growth
VND bn309Q2/26
1.Revenue & growth
VND bn309Q2/26
2.Profit & growth
VND bn1,75Q2/26
3.Profit mix (Penman)
VND bn-81,2Q2/26
4.Margins & cost structure
%-0.1%Q2/26
5.Returns & cash cycle
% · days-13.4%Q2/26
6.Earnings quality & cash
VND bn101Q2/26
7.Asset structure
VND bn811Q2/26
8.Funding & debt health
VND bn · times811Q2/26
9.Revenue backlog
VND bn2,37Q2/26
10.Valuation
times · %-1,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %173Q2/26
Adjusted EPS growth, latest quarter
-47.5%
Average adjusted EPS growth, 3 quarters
229%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26